Zevra Therapeutics, Inc. SEC filings ZVRA
Zevra Therapeutics, Inc. has 870 filings in SEC EDGAR's recent list, going back to May 6, 2008. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 9, 2026 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 424B5 | Prospectus supplement | Aug 9, 2024 | — |
| 424B5 | Prospectus supplement | Aug 8, 2024 | — |
| 424B2 | Prospectus | Jul 12, 2024 | — |
| S-3 | Shelf registration | Jun 4, 2024 | — |
| 424B3 | Prospectus | Apr 10, 2024 | — |
| S-3/A | Filing | Apr 8, 2024 | — |
| S-8 | Employee stock plan registration | Apr 2, 2024 | — |
| S-8 | Employee stock plan registration | Apr 2, 2024 | — |
| S-3 | Shelf registration | Feb 5, 2024 | — |
| 424B5 | Prospectus supplement | Nov 22, 2023 | — |
| 424B3 | Prospectus | Oct 10, 2023 | — |
| S-4/A | Filing | Oct 6, 2023 | — |
| S-4 | Registration for a merger or exchange | Sep 29, 2023 | — |
| S-8 | Employee stock plan registration | Mar 7, 2023 | — |
| S-8 | Employee stock plan registration | Mar 7, 2023 | — |
| 424B3 | Prospectus | Feb 2, 2022 | — |
| POS AM | Filing | Jan 25, 2022 | — |
| 424B3 | Prospectus | Jan 20, 2022 | — |
| 424B3 | Prospectus | Dec 20, 2021 | — |
| 424B3 | Prospectus | Dec 14, 2021 | — |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| 424B3 | Prospectus | Oct 19, 2021 | — |
| 424B3 | Prospectus | Aug 20, 2021 | — |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| 424B3 | Prospectus | Aug 13, 2021 | — |
| 424B3 | Prospectus | Jul 21, 2021 | — |
| 424B5 | Prospectus supplement | Jul 12, 2021 | — |
| 424B5 | Prospectus supplement | Jul 12, 2021 | — |
| 424B3 | Prospectus | Jul 12, 2021 | — |
| 424B5 | Prospectus supplement | Jul 7, 2021 | — |
| S-3 | Shelf registration | Jul 2, 2021 | — |
| S-3 | Shelf registration | Jun 25, 2021 | — |
| S-8 | Employee stock plan registration | Jun 25, 2021 | — |
| 424B3 | Prospectus | Jun 24, 2021 | — |
| 424B3 | Prospectus | Jun 24, 2021 | — |
| 424B3 | Prospectus | May 14, 2021 | — |
| 424B3 | Prospectus | May 13, 2021 | — |
| 424B3 | Prospectus | Apr 8, 2021 | — |
| 424B3 | Prospectus | Mar 12, 2021 | — |
| 424B3 | Prospectus | Mar 3, 2021 | — |
| 424B5 | Prospectus supplement | Feb 16, 2021 | — |
| 424B3 | Prospectus | Feb 9, 2021 | — |
| S-3 | Shelf registration | Feb 9, 2021 | — |
| S-8 | Employee stock plan registration | Feb 4, 2021 | — |
| 424B3 | Prospectus | Jan 27, 2021 | — |
| 424B3 | Prospectus | Jan 26, 2021 | — |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| S-3 | Shelf registration | Jan 13, 2021 | — |
| 424B4 | Prospectus | Jan 11, 2021 | — |
| S-1MEF | Filing | Jan 7, 2021 | — |
| S-1/A | Amended registration statement | Jan 5, 2021 | — |
| S-1/A | Amended registration statement | Dec 28, 2020 | — |
| S-1/A | Amended registration statement | Dec 21, 2020 | — |
| S-1 | Registration statement | Nov 25, 2020 | — |
| 424B5 | Prospectus supplement | Apr 10, 2020 | — |
| S-3/A | Filing | Apr 1, 2020 | — |
| S-8 | Employee stock plan registration | Feb 28, 2020 | — |
| 424B5 | Prospectus supplement | Feb 18, 2020 | — |
| 424B5 | Prospectus supplement | Feb 18, 2020 | — |
| 424B5 | Prospectus supplement | Feb 18, 2020 | — |
| S-3 | Shelf registration | Oct 16, 2019 | — |
| S-8 | Employee stock plan registration | Mar 1, 2019 | — |
| 424B5 | Prospectus supplement | Mar 1, 2019 | — |
| 424B5 | Prospectus supplement | Mar 1, 2019 | — |
| 424B5 | Prospectus supplement | Oct 5, 2018 | — |
| 424B5 | Prospectus supplement | Oct 4, 2018 | — |
| 424B5 | Prospectus supplement | Sep 4, 2018 | — |
| S-8 | Employee stock plan registration | Mar 30, 2018 | — |
| S-8 | Employee stock plan registration | Mar 21, 2017 | — |
| 424B5 | Prospectus supplement | Oct 17, 2016 | — |
| S-3 | Shelf registration | Oct 3, 2016 | — |
| S-8 | Employee stock plan registration | Mar 23, 2016 | — |
| S-1 | Registration statement | Dec 18, 2015 | — |
| S-8 | Employee stock plan registration | Apr 29, 2015 | — |
| 424B4 | Prospectus | Apr 16, 2015 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Apr 16, 2015 | — |
| S-1/A | Amended registration statement | Apr 9, 2015 | — |
| S-1/A | Amended registration statement | Apr 3, 2015 | — |
| S-1 | Registration statement | Mar 11, 2015 | — |
Showing 82 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZVRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1434647
- Former names
- KEMPHARM, INC (until Feb 24, 2023); KEMPHARM INC (until Jun 30, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.